Li Yu Selected Research

Li Yu Research Topics

Disease

147	Neoplasms (Cancer) 03/2022 - 02/2004
60	Infections 02/2022 - 06/2007
55	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2005
47	Leukemia 01/2022 - 03/2001
46	Inflammation (Inflammations) 05/2022 - 11/2004
36	Cough 02/2022 - 11/2004
19	Neoplasm Metastasis (Metastasis) 12/2020 - 11/2002
17	COVID-19 12/2022 - 01/2020
17	Sepsis (Septicemia) 11/2022 - 03/2015
17	Brain Ischemia (Cerebral Ischemia) 06/2022 - 03/2012
17	Chronic Cough 01/2021 - 05/2008
16	Asthma (Bronchial Asthma) 03/2022 - 11/2004
16	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 01/2002
16	Carcinogenesis 12/2021 - 08/2005
15	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 08/2008
15	Multiple Myeloma 12/2019 - 12/2006
14	Lymphoma (Lymphomas) 01/2021 - 03/2000
13	Reperfusion Injury 06/2022 - 12/2015
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2008
13	Gastroesophageal Reflux (GERD) 09/2021 - 01/2009
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 05/2014
11	Hypoxia (Hypoxemia) 01/2022 - 01/2013
11	Starvation 10/2021 - 06/2010
10	Endometrial Neoplasms (Endometrial Cancer) 12/2016 - 04/2005
9	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2007
9	Body Weight (Weight, Body) 07/2022 - 03/2014
9	Fibrosis (Cirrhosis) 07/2022 - 03/2014
9	Disease Progression 01/2022 - 05/2012
9	Neutropenia 01/2022 - 04/2011
8	Hypersensitivity (Allergy) 02/2022 - 05/2011
8	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 07/2003
8	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 09/2003
8	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 02/2006
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2019 - 06/2011
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022 - 03/2012
7	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2014
7	Necrosis 01/2022 - 01/2014
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2020 - 02/2011
7	Heart Failure 01/2020 - 12/2010
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2016 - 06/2007
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2014 - 04/2006
6	Toxoplasmosis 02/2022 - 06/2012
6	Pain (Aches) 01/2022 - 05/2005
6	Hemorrhage 01/2022 - 06/2010
6	Stroke (Strokes) 11/2021 - 09/2017
6	Thrombosis (Thrombus) 09/2021 - 09/2010

Drug/Important Bio-Agent (IBA)

83	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2002
40	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2006
28	Messenger RNA (mRNA)IBA 05/2022 - 07/2003
24	AntigensIBA 12/2022 - 10/2010
23	CytokinesIBA 01/2022 - 03/2000
22	Pharmaceutical PreparationsIBA 11/2021 - 02/2004
21	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2005
19	Biological ProductsIBA 01/2022 - 08/2008
18	VaccinesIBA 12/2022 - 12/2008
18	Decitabine FDA Link 12/2021 - 05/2009
17	MicroRNAs (MicroRNA)IBA 02/2021 - 08/2008
17	Long Noncoding RNAIBA 01/2021 - 01/2015
15	Interleukin-6 (Interleukin 6)IBA 05/2022 - 03/2000
15	Capsaicin (Zostrix)FDA Link 01/2022 - 11/2004
12	Therapeutic UsesIBA 01/2022 - 05/2007
11	AcidsIBA 01/2022 - 05/2011
11	Oxygen (Dioxygen)IBA 01/2022 - 01/2012
10	EnzymesIBA 02/2022 - 05/2014
10	Indicators and Reagents (Reagents)IBA 02/2022 - 06/2007
10	Phosphotransferases (Kinase)IBA 01/2022 - 06/2010
10	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 12/2010
10	Bortezomib (Velcade)FDA Link 12/2012 - 12/2006
9	Immunoglobulin G (IgG)IBA 01/2022 - 10/2012
9	AntibodiesIBA 01/2021 - 01/2012
8	Neutralizing AntibodiesIBA 12/2022 - 11/2014
8	Estrogen ReceptorsIBA 01/2022 - 04/2005
8	Estrogens (Estrogen)FDA Link 01/2022 - 04/2005
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2012
8	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2010
8	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 03/2000
7	CreatinineIBA 01/2022 - 07/2018
7	Peptides (Polypeptides)IBA 01/2022 - 09/2009
7	Neuroprotective AgentsIBA 02/2021 - 12/2011
7	AntioxidantsIBA 01/2021 - 01/2019
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2017
7	C-Reactive ProteinIBA 12/2020 - 02/2016
6	Retinaldehyde (Retinal)IBA 08/2022 - 02/2018
6	CollagenIBA 07/2022 - 01/2018
6	hydroxysafflor yellow AIBA 06/2022 - 07/2017
6	salicylhydroxamic acid (SHAM)IBA 05/2022 - 01/2019
6	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2009
6	Monoclonal AntibodiesIBA 01/2022 - 01/2011
6	Anaplastic Lymphoma KinaseIBA 01/2022 - 07/2016
6	CateninsIBA 01/2022 - 08/2012
6	Circular RNAIBA 12/2021 - 10/2019

Therapy/Procedure

98	Therapeutics 07/2022 - 04/2005
32	Hematopoietic Stem Cell Transplantation 01/2021 - 11/2007
29	Drug Therapy (Chemotherapy) 12/2021 - 06/2007
20	Transplantation 01/2021 - 06/2007
16	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2021 - 02/2006
15	Immunotherapy 01/2022 - 04/2010
12	Aftercare (After-Treatment) 10/2020 - 04/2004
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2010
8	Stem Cell Transplantation 09/2019 - 01/2002